298 related articles for article (PubMed ID: 20707381)
1. Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: a multifunctional nanocarrier system for cancer diagnosis and treatment.
Cho HS; Dong Z; Pauletti GM; Zhang J; Xu H; Gu H; Wang L; Ewing RC; Huth C; Wang F; Shi D
ACS Nano; 2010 Sep; 4(9):5398-404. PubMed ID: 20707381
[TBL] [Abstract][Full Text] [Related]
2. Cooperative dual-activity targeted nanomedicine for specific and effective prostate cancer therapy.
Yang HW; Hua MY; Liu HL; Tsai RY; Chuang CK; Chu PC; Wu PY; Chang YH; Chuang HC; Yu KJ; Pang ST
ACS Nano; 2012 Feb; 6(2):1795-805. PubMed ID: 22248493
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V
J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666
[TBL] [Abstract][Full Text] [Related]
4. Magnetic-nanoparticle-modified paclitaxel for targeted therapy for prostate cancer.
Hua MY; Yang HW; Chuang CK; Tsai RY; Chen WJ; Chuang KL; Chang YH; Chuang HC; Pang ST
Biomaterials; 2010 Oct; 31(28):7355-63. PubMed ID: 20609471
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-
Wu M; Wang Y; Wang Y; Zhang M; Luo Y; Tang J; Wang Z; Wang D; Hao L; Wang Z
Int J Nanomedicine; 2017; 12():5313-5330. PubMed ID: 28794625
[TBL] [Abstract][Full Text] [Related]
6. Surfactant-free, drug-quantum-dot coloaded poly(lactide-co-glycolide) nanoparticles: towards multifunctional nanoparticles.
Nehilla BJ; Allen PG; Desai TA
ACS Nano; 2008 Mar; 2(3):538-44. PubMed ID: 19206580
[TBL] [Abstract][Full Text] [Related]
7. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC
J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508
[TBL] [Abstract][Full Text] [Related]
8. Improved therapeutic effect of folate-decorated PLGA-PEG nanoparticles for endometrial carcinoma.
Liang C; Yang Y; Ling Y; Huang Y; Li T; Li X
Bioorg Med Chem; 2011 Jul; 19(13):4057-66. PubMed ID: 21641806
[TBL] [Abstract][Full Text] [Related]
9. Quantum dots conjugated with Fe3O4-filled carbon nanotubes for cancer-targeted imaging and magnetically guided drug delivery.
Chen ML; He YJ; Chen XW; Wang JH
Langmuir; 2012 Nov; 28(47):16469-76. PubMed ID: 23131026
[TBL] [Abstract][Full Text] [Related]
10. Image-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles.
Yu MK; Kim D; Lee IH; So JS; Jeong YY; Jon S
Small; 2011 Aug; 7(15):2241-9. PubMed ID: 21648076
[TBL] [Abstract][Full Text] [Related]
11. In vitro targeted imaging and delivery of camptothecin using cetuximab-conjugated multifunctional PLGA-ZnS nanoparticles.
Deepagan VG; Sarmento B; Menon D; Nascimento A; Jayasree A; Sreeranganathan M; Koyakutty M; Nair SV; Rangasamy J
Nanomedicine (Lond); 2012 Apr; 7(4):507-19. PubMed ID: 22471719
[TBL] [Abstract][Full Text] [Related]
12. Dual docetaxel/superparamagnetic iron oxide loaded nanoparticles for both targeting magnetic resonance imaging and cancer therapy.
Ling Y; Wei K; Luo Y; Gao X; Zhong S
Biomaterials; 2011 Oct; 32(29):7139-50. PubMed ID: 21726899
[TBL] [Abstract][Full Text] [Related]
13. Construction and in vitro/in vivo targeting of PSMA-targeted nanoscale microbubbles in prostate cancer.
Wang L; Li L; Guo Y; Tong H; Fan X; Ding J; Huang H
Prostate; 2013 Aug; 73(11):1147-58. PubMed ID: 23532872
[TBL] [Abstract][Full Text] [Related]
14. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
Mukerjee A; Vishwanatha JK
Anticancer Res; 2009 Oct; 29(10):3867-75. PubMed ID: 19846921
[TBL] [Abstract][Full Text] [Related]
15. Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging.
Schleich N; Sibret P; Danhier P; Ucakar B; Laurent S; Muller RN; Jérôme C; Gallez B; Préat V; Danhier F
Int J Pharm; 2013 Apr; 447(1-2):94-101. PubMed ID: 23485340
[TBL] [Abstract][Full Text] [Related]
16. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
17. Folate-targeting magnetic core-shell nanocarriers for selective drug release and imaging.
Wang H; Wang S; Liao Z; Zhao P; Su W; Niu R; Chang J
Int J Pharm; 2012 Jul; 430(1-2):342-9. PubMed ID: 22525087
[TBL] [Abstract][Full Text] [Related]
18. Multimodal imaging of nanovaccine carriers targeted to human dendritic cells.
Cruz LJ; Tacken PJ; Bonetto F; Buschow SI; Croes HJ; Wijers M; de Vries IJ; Figdor CG
Mol Pharm; 2011 Apr; 8(2):520-31. PubMed ID: 21381651
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
20. A paclitaxel-conjugated adenovirus vector for targeted drug delivery for tumor therapy.
Shan L; Cui S; Du C; Wan S; Qian Z; Achilefu S; Gu Y
Biomaterials; 2012 Jan; 33(1):146-62. PubMed ID: 21959006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
